Atopic Eczema Treatment Market By Type (Topical, Oral, and Injectable), By Application (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2020 – 2026
The pandemic continues to cause unprecedented disruption across industries worldwide.Get detailed insights regarding the impact of COVID-19 on the market. Request Sample
Industry Insights
[195+ Pages Report] According to the report published by Facts & Factors, the global atopic eczema treatment market was estimated at approximately USD 18,057.4 Million in 2019 and is anticipated to generate revenue of around USD 34,089.3 Million by end of 2026, growing at a CAGR of around 10.36% between 2020 and 2026.
Global Atopic Eczema Treatment Market: Overview
Eczema (atopic dermatitis) is a skin disease that causes itchiness on the skin and making the skin surface look dry and red. It's more common in kids, but it can strike someone at any age. Atopic dermatitis is a long-term (chronic) condition that flares up from time to time. There is yet no treatment for atopic eczema, but doctors suggest self-care treatments helping to ease itching and deter new outbreaks. Some treatments that are considered to be beneficial are avoiding any usage of harsh soaps, moisturizing the skin regularly, and applying medicated creams or ointments.
Global Atopic Eczema Treatment Market: Growth Factors
The atopic eczema treatment industry has gained momentum in recent years as people have become more knowledgeable of the disease's care options. Government initiatives to offer quality and more affordable care, as well as the presence of attractive payment plans, is expected to give the industry a boost. One of the big roadblocks in the market's upward climb is the high cost of therapeutics. Affordable healthcare policies, on the other hand, are being implemented in all main countries, affecting company price plans as well as payment possibilities. Nevertheless, there are multiple opportunities where a permanent cure for the disease could be developed by the key players or else can develop a systematic treatment to recover affected patients from atopic eczema infections.
Global Atopic Eczema Treatment Market: Segmentation
Based on the type segment, the atopic eczema treatment market is divided into topical, oral, and injectable, out of which, the topical type holds the maximum market share as they are widely prescribed and used drugs in atopic eczema treatments. They are generally using in combination with moisturizers or emollients as they give more effective results in this way. These topical creams can be easily applied and washed from the skin. These topical moisturizers are anti-inflammatory helping to lower skin itching and rash, thus helping to lock in the water and avoid more dryness. On the basis of application, the market is segmented into hospital pharmacies, retail pharmacies, online pharmacies, and others. The segment of online pharmacies holds the largest share as compared with other segments as it gives access to eczema treatment medicines with various brands to choose from with varying prices. Online pharmacies are also helpful for those who have a busy lifestyle and do not have time to visit a local pharmacy or else for the people who live a long way from their nearest pharmacy. The elderly people who are unable to travel independently also prefer ordering their medicines from online pharmacies. Online pharmacies also helped in delivering medicines to the patients who were under lockdown and were unable to get their medicines from the local pharmacy store. It also helped in delivering the medicines on time as COVID-19 had an impact on the delivery duration of medicines in the local pharmacies.
Global Atopic Eczema Treatment Market: Regional Analysis
The region of North America is anticipated to dominate the atopic eczema treatment market over the forecasted period owing to well-developed technologies, an increase in patients with poor protein filaggrin levels, an increase in the incidence of atopic disease, high healthcare expenditures, and increased government funding for R&D. Furthermore, the demand in this area has grown owing to increased R&D activities and the presence of major companies in the region. Owing to the surging government funding for research and development and the availability of funds for research, Europe ranks second in the global atopic eczema treatment industry. Over the forecasted timeframe, this is likely to continue to drive the European economy. Countries such as Germany and France, for example, are growing their investments in healthcare. Due to rapidly evolving healthcare technologies, a large patient population, and high healthcare spending, Asia Pacific is the fastest growing atopic eczema treatment market. Furthermore, developing demand for new treatment approaches in countries such as India and South Korea is projected to emerge as the world's fastest-growing market. Furthermore, the demand for high-quality medical products is expected to lead to an increased usage of advanced equipment, which will boost atopic eczema treatment market growth in the area.
Global Atopic Eczema Treatment Market: Competitive Players
The major players dominating the global atopic eczema treatment market in terms of revenue and development are Encore Dermatology Inc., AbbieVie Inc., F. Hoffmann-La Roche AG, Novartis AG, GlaxoSmithKline plc.,Regeneron Pharmaceuticals Inc., Medimmune LLC. (AstraZeneca), LEO Pharma A/S, Sanofi S.A, Valeant Pharmaceuticals Inc., Pfizer Inc., and Others. To achieve a reputable foothold in the global economy, these big players have used a range of tactics, including signing deals, shares, leases, alliances, joint ventures, new product releases, collaborations, and mergers and acquisitions. These big companies have used a number of techniques to obtain a reputable spot in the global economy, including signing agreements, stakes, leases, partnerships, joint ventures, new product launches, collaborations, and mergers and acquisitions. For instance, in May 2016, Pfizer Inc. acquired Anacor Pharmaceuticals, Inc. for USD 99.25 per Anacor share. This acquisition would help Pfizer to a position where it would be able to address a major medical issue and develop medicine or find a cure for a major population suffering from mild-to-moderate atopic dermatitis, for which there are currently few safe topical remedies.
The pandemic continues to cause unprecedented disruption across industries worldwide.Get detailed insights regarding the impact of COVID-19 on the market. Request Sample
10.1. Key Insights from Primary Interviews & Surveys Respondents
10.2. Key Takeaways from Analysts, Consultants, and Industry Leaders
Chapter 11 Research Approach & Methodology
11.1. Report Description
11.2. Research Scope
11.3. Research Methodology
11.3.1. Secondary Research
11.3.2. Primary Research
11.3.3. Statistical Models
11.3.3.1. Company Share Analysis Model
11.3.3.2. Revenue Based Modeling
11.3.4. Research Limitations
List of Figures
Fig.1 Product Picture of Atopic Eczema Treatment
Fig.2 Global Atopic Eczema Treatment Market, 2016 – 2026 (USD Million)
Fig.3 Global Atopic Eczema Treatment Market Absolute Revenue Opportunity, 2016 – 2026 (USD Million)
Fig.4 Global Atopic Eczema Treatment Market Incremental Revenue Opportunity, 2020 – 2026 (USD Million)
Fig.5 Global Atopic Eczema Treatment Market Share, by Type, 2019 & 2026 (USD Million)
Fig.6 Global Topical Atopic Eczema Treatment Market, 2016 – 2026 (USD Million)
Fig.7 Global Oral Atopic Eczema Treatment Market, 2016 – 2026 (USD Million)
Fig.8 Global Injectable Atopic Eczema Treatment Market, 2016 – 2026 (USD Million)
Fig.9 Global Atopic Eczema Treatment Market Share, by Application, 2019 & 2026 (USD Million)
Fig.10 Global Hospital Pharmacies Atopic Eczema Treatment Market, 2016 – 2026 (USD Million)
Fig.11 Global Retail Pharmacies Atopic Eczema Treatment Market, 2016 – 2026 (USD Million)
Fig.12 Global Online Pharmacies Atopic Eczema Treatment Market, 2016 – 2026 (USD Million)
Fig.13 Global Atopic Eczema Treatment Market Share, by Region, 2019 & 2026 (USD Million)
Fig.14 North America Atopic Eczema Treatment Market, 2016 – 2026 (USD Million)
Fig.15 U.S. Atopic Eczema Treatment Market, 2016 – 2026 (USD Million)
Fig.16 Canada Atopic Eczema Treatment Market, 2016 – 2026 (USD Million)
Fig.17 Europe Atopic Eczema Treatment Market, 2016 – 2026 (USD Million)
Fig.18 Germany Atopic Eczema Treatment Market, 2016 – 2026 (USD Million)
Fig.19 France Atopic Eczema Treatment Market, 2016 – 2026 (USD Million)
Fig.20 U.K. Atopic Eczema Treatment Market, 2016 – 2026 (USD Million)
Fig.21 Italy Atopic Eczema Treatment Market, 2016 – 2026 (USD Million)
Fig.22 Spain Atopic Eczema Treatment Market, 2016 – 2026 (USD Million)
Fig.23 Rest of Europe Atopic Eczema Treatment Market, 2016 – 2026 (USD Million)
Fig.24 Asia Pacific Atopic Eczema Treatment Market, 2016 – 2026 (USD Million)
Fig.25 China Atopic Eczema Treatment Market, 2016 – 2026 (USD Million)
Fig.26 Japan Atopic Eczema Treatment Market, 2016 – 2026 (USD Million)
Fig.27 India Atopic Eczema Treatment Market, 2016 – 2026 (USD Million)
Fig.28 South Korea Atopic Eczema Treatment Market, 2016 – 2026 (USD Million)
Fig.29 South-East Asia Atopic Eczema Treatment Market, 2016 – 2026 (USD Million)
Fig.30 Rest of Asia Pacific Atopic Eczema Treatment Market, 2016 – 2026 (USD Million)
Fig.31 Latin America Atopic Eczema Treatment Market, 2016 – 2026 (USD Million)
Fig.32 Brazil Atopic Eczema Treatment Market, 2016 – 2026 (USD Million)
Fig.33 Mexico Atopic Eczema Treatment Market, 2016 – 2026 (USD Million)
Fig.34 Rest of Latin America Atopic Eczema Treatment Market, 2016 – 2026 (USD Million)
Fig.35 The Middle-East and Africa Atopic Eczema Treatment Market, 2016 – 2026 (USD Million)
Fig.36 GCC Countries Atopic Eczema Treatment Market, 2016 – 2026 (USD Million)
Fig.37 South Africa Atopic Eczema Treatment Market, 2016 – 2026 (USD Million)
Fig.38 Rest of Middle-East Africa Atopic Eczema Treatment Market, 2016 – 2026 (USD Million)
Fig.39 Competitor Market Share – Revenue
Fig.40 Encore Dermatology Inc. Revenue and Growth Rate
Fig.41 Encore Dermatology Inc. Market Share
Fig.42 AbbieVie Inc. Revenue and Growth Rate
Fig.43 AbbieVie Inc. Market Share
Fig.44 F. Hoffmann-La Roche AG Revenue and Growth Rate
Fig.45 F. Hoffmann-La Roche AG Market Share
Fig.46 Novartis AG Revenue and Growth Rate
Fig.47 Novartis AG Market Share
Fig.48 Glaxosmithkline plc. Revenue and Growth Rate
Fig.49 Glaxosmithkline plc. Market Share
Fig.50 Regeneron Pharmaceuticals Inc. Revenue and Growth Rate
Fig.51 Regeneron Pharmaceuticals Inc. Market Share
Fig.52 Medimmune LLC. (Astrazeneca) Revenue and Growth Rate
Fig.53 Medimmune LLC. (Astrazeneca) Market Share
Fig.54 LEO Pharma A/S Revenue and Growth Rate
Fig.55 LEO Pharma A/S Market Share
Fig.56 Sanofi S.A Revenue and Growth Rate
Fig.57 Sanofi S.A Market Share
Fig.58 Valeant Pharmaceuticals Inc. Revenue and Growth Rate
Fig.59 Valeant Pharmaceuticals Inc. Market Share
Fig.60 Pfizer Inc. Revenue and Growth Rate
Fig.61 Pfizer Inc. Market Share
Fig.62 Others Revenue and Growth Rate
Fig.63 Others Market Share
Fig.64 Market Dynamics
Fig.65 Global Atopic Eczema Treatment – Value Chain Analysis
Fig.66 Key Mandates and Regulations
Fig.67 Technology Roadmap and Timeline
Fig.68 Market Attractiveness Analysis – By Type
Fig.69 Market Attractiveness Analysis – By Application
Fig.70 Market Attractiveness Analysis – By Region
Fig.71 Atopic Eczema Treatment Industrial Chain Analysis
Fig.72 Market Channels
Fig.73 Marketing Channel Development Trend
Fig.74 Growth in World Gross Product, 2008-2018
List of Tables
Table 1 Global Atopic Eczema Treatment Market, 2019 & 2026 (USD Million)
Table 2 Global Atopic Eczema Treatment Market, by Type, 2016 – 2026 (USD Million)
Table 3 Global Atopic Eczema Treatment Market, by Application, 2016 – 2026 (USD Million)
Table 4 Global Atopic Eczema Treatment Market, by Region, 2016 – 2026 (USD Million)
Table 5 North America Atopic Eczema Treatment Market, by Country, 2016 – 2026 (USD Million)
Table 6 North America Atopic Eczema Treatment Market, by Type, 2016 – 2026 (USD Million)
Table 7 North America Atopic Eczema Treatment Market, by Application, 2016 – 2026 (USD Million)
Table 8 Europe Atopic Eczema Treatment Market, by Country, 2016 – 2026 (USD Million)
Table 9 Europe Atopic Eczema Treatment Market, by Type, 2016 – 2026 (USD Million)
Table 10 Europe Atopic Eczema Treatment Market, by Application, 2016 – 2026 (USD Million)
Table 11 Asia Pacific Atopic Eczema Treatment Market, by Country, 2016 – 2026 (USD Million)
Table 12 Asia Pacific Atopic Eczema Treatment Market, by Type, 2016 – 2026 (USD Million)
Table 13 Asia Pacific Atopic Eczema Treatment Market, by Application, 2016 – 2026 (USD Million)
Table 14 Latin America Atopic Eczema Treatment Market, by Country, 2016 – 2026 (USD Million)
Table 15 Latin America Atopic Eczema Treatment Market, by Type, 2016 – 2026 (USD Million)
Table 16 Latin America Atopic Eczema Treatment Market, by Application, 2016 – 2026 (USD Million)
Table 17 The Middle-East and Africa Atopic Eczema Treatment Market, by Country, 2016 – 2026 (USD Million)
Table 18 The Middle-East and Africa Atopic Eczema Treatment Market, by Type, 2016 – 2026 (USD Million)
Table 19 The Middle-East and Africa Atopic Eczema Treatment Market, by Application, 2016 – 2026 (USD Million)
Table 20 Global Atopic Eczema Treatment Market - Company Revenue Analysis, 2016 – 2019 (USD Million)
Table 21 Global Atopic Eczema Treatment Market - Company Revenue Share Analysis, 2016 – 2019 (%)
Table 22 Acquisitions and Mergers
Table 23 Market Drivers – Impact Analysis
Table 24 Market Restraints
Table 25 Market Opportunities
Table 26 Major Buyers of Atopic Eczema Treatment
Table 27 Distributors/Traders of Atopic Eczema Treatment by Region
Covid-19
Atopic Eczema Treatment Market
The pandemic continues to cause unprecedented disruption across industries worldwide.Get detailed insights regarding the impact of COVID-19 on the market. Request Sample
According to Facts and Factors research report, the global Atopic Eczema Treatment Market accrued earnings worth approximately XX (USD Billion) in 2020 and is predicted to gain revenue of about XX(USD Billion) by 2028, is set to record a CAGR of nearly XX% over the period from 2021 to 2028.
North America will contribute lucratively towards the global market value over the estimated timeline. The regional market surge is subject to large-scale presence of giant participants in countries such as the U.S. Apart from this, favorable compensation policies along with high acceptance of new Atopic Eczema Treatment Market will drive regional market trends.
With regional governments enforcing strict laws pertaining to drug abuse, the market for Atopic Eczema Treatment Market in North America is set to witness exponential growth over years to come. Legalization of cannabis in countries such as Canada and U.S. through passing of acts in parliament is likely to enlarge scope of Atopic Eczema Treatment Market in North America over coming decade.
[212+ Pages Report] According to Facts Factors, the global dental periodontics market report encompasses the complete market breakdown structure. The global dental periodontics market is estimated to have witnessed a value of USD 15 Billion in 2020 and with growth at a CAGR of 10% during 2021-202...
Published Date : 23-Nov-2021 |
| Category :
| Pages : 212 | Format : Read more
[197+ Pages Report] Facts Factors published a report on the global DNA Forensics Market that encompasses a complete market synopsis. The DNA Forensics market is expected to grow at a CAGR value of 19% from an initial value of USD 30100 Million in 2020 to USD 6000 Million by 2026.
Global DNA For...
Published Date : 22-Nov-2021 |
| Category :
| Pages : 197 | Format : Read more
Glyphicons
Global Atopic Eczema Treatment Market: Overview
